Gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The initial patients did not receive chemotherapy, radiotherapy or other anti-tumor treatment before the start of clinical trial; (2) The age ranged from 40 to 75 years old; (3) Male or non pregnant and lactating women; (4) Gastric adenocarcinoma was confirmed by pathology; (5) Patients with T stage T3 or above were judged by naked eyes during operation, and there was no distant metastasis. The standard D2 radical operation was feasible (AJCC, 7th Edition, 2010); (6) Function status: 0-1 (ECoG); (7) Sign informed consent voluntarily.
Exclusion criteria
Exclusion criteria: (1) There was a history of other malignant tumors within 5 years; (2) Any M1 was found during the operation; (3) Patients with serious or uncontrolled medical diseases and infections (including atrial fibrillation, angina pectoris, cardiac insufficiency, ejection fraction less than 50%, refractory hypertension, etc.); (4) Patients with seizures requiring treatment (e.g., steroids or antiepileptic therapy); (5) Patients with serious or uncontrollable mental illness; (6) Drug abuse and medical, psychological or social conditions may interfere with patients' participation in the study or affect the evaluation of research results; (7) Any unstable condition or situation that may endanger the patient's safety and compliance; (8) They are being treated with anticancer drugs from other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival rate; | — |
Countries
China
Contacts
Huashan Hospital Affiliated to Fudan University